Primary and subgroup analysis from the Phase 2b CORAL trial of nalbuphine ER for the treatment of patients with IPF-related ...

A former alderman and Davenport mayoral candidate has filed suit against the Davenport City Council, accusing the council of ...

Final randomized Phase 2 Bria-IMT™ survival and quality of life data to be presented Biomarker analyses from the ongoing Phase 3 study evaluating ...

The Safe Streets For All project is continuing onward for the city, with the most recent step in the process being a presentation on the project to the city Planning Commission. John Hartley with Stan ...

Includes results from additional continuous glucose monitoring (CGM)-based outcomes which demonstrate significant and ...

Company Will Discuss Data and Report First Quarter 2026 Financial Results on May 8 - SOUTH SAN FRANCISCO, Calif., April 30, ...

A Research Evening offered students the opportunity to share different research findings they conducted for course ...

Experts cautioned against reading too much into the incidence data but agreed the issue warrants additional research.

STOCKHOLM, SE / ACCESS Newswire / April 29, 2026 /Vicore Pharma Holding AB (Nasdaq Stockholm:VICO), a clinical-stage biopharmaceutical company unlocking the potential of a novel class of drugs, ...

At least one federal government department is assessing how much space it would need to bring public servants back into the ...

Q: ISC 2026 will be held from 6–10 September 2026. Are there any deadlines on the horizon that delegates, speakers, sponsors, ...

Beacon Therapeutics Holdings Limited (Beacon Therapeutics or the Company), a leading clinical-stage biotechnology company with a mission ...